Armata Pharmaceuticals, Inc. Common Stock — Chart, Price & News (NYSE:ARMP) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 308.36 K
Employee 61
Founded 1989
CEO N/A
Website www.armatapharma.com
Headquarter Washington, United States
FIGI BBG000BD7CF8
Industry Biotechnology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

Price to earnings ratio

-1.31

Price to sales ratio

46.41

News

H.C. Wainwright lowers Armata Pharmaceuticals stock price target to $15

Armata Pharmaceuticals stock gains on FDA designation

FDA grants QIDP status to Armata’s staph infection treatment

Innoviva stock gains BTIG coverage with buy rating on royalty windfall

Armata to advance bacteriophage therapy to phase 3 for S. aureus

Jones Trading initiates coverage on Armata Pharmaceuticals stock with Buy rating

Armata Pharma earnings missed by $0.24, revenue fell short of estimates

Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates

Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates

Armata Pharmaceuticals commissions phage manufacturing facility

Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates

Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates